Literature DB >> 24474760

O-GlcNAcylation regulates EZH2 protein stability and function.

Chi-Shuen Chu1, Pei-Wen Lo, Yi-Hsien Yeh, Pang-Hung Hsu, Shih-Huan Peng, Yu-Ching Teng, Ming-Lun Kang, Chi-Huey Wong, Li-Jung Juan.   

Abstract

O-linked N-acetylglucosamine (GlcNAc) transferase (OGT) is the only known enzyme that catalyzes the O-GlcNAcylation of proteins at the Ser or Thr side chain hydroxyl group. OGT participates in transcriptional and epigenetic regulation, and dysregulation of OGT has been implicated in diseases such as cancer. However, the underlying mechanism is largely unknown. Here we show that OGT is required for the trimethylation of histone 3 at K27 to form the product H3K27me3, a process catalyzed by the histone methyltransferase enhancer of zeste homolog 2 (EZH2) in the polycomb repressive complex 2 (PRC2). H3K27me3 is one of the most important histone modifications to mark the transcriptionally silenced chromatin. We found that the level of H3K27me3, but not other H3 methylation products, was greatly reduced upon OGT depletion. OGT knockdown specifically down-regulated the protein stability of EZH2, without altering the levels of H3K27 demethylases UTX and JMJD3, and disrupted the integrity of the PRC2 complex. Furthermore, the interaction of OGT and EZH2/PRC2 was detected by coimmunoprecipitation and cosedimentation experiments. Importantly, we identified that serine 75 is the site for EZH2 O-GlcNAcylation, and the EZH2 mutant S75A exhibited reduction in stability. Finally, microarray and ChIP analysis have characterized a specific subset of potential tumor suppressor genes subject to repression via the OGT-EZH2 axis. Together these results indicate that OGT-mediated O-GlcNAcylation at S75 stabilizes EZH2 and hence facilitates the formation of H3K27me3. The study not only uncovers a functional posttranslational modification of EZH2 but also reveals a unique epigenetic role of OGT in regulating histone methylation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24474760      PMCID: PMC3910655          DOI: 10.1073/pnas.1323226111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  58 in total

1.  O-GlcNAc regulates pluripotency and reprogramming by directly acting on core components of the pluripotency network.

Authors:  Hyonchol Jang; Tae Wan Kim; Sungho Yoon; Soo-Youn Choi; Tae-Wook Kang; Seon-Young Kim; Yoo-Wook Kwon; Eun-Jung Cho; Hong-Duk Youn
Journal:  Cell Stem Cell       Date:  2012-05-17       Impact factor: 24.633

2.  Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability.

Authors:  Won Ho Yang; Ji Eun Kim; Hyung Wook Nam; Jung Won Ju; Hoe Suk Kim; Yu Sam Kim; Jin Won Cho
Journal:  Nat Cell Biol       Date:  2006-09-10       Impact factor: 28.824

3.  Beta-N-acetylglucosamine (O-GlcNAc) is part of the histone code.

Authors:  Kaoru Sakabe; Zihao Wang; Gerald W Hart
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-02       Impact factor: 11.205

4.  β-N-Acetylglucosamine (O-GlcNAc) is a novel regulator of mitosis-specific phosphorylations on histone H3.

Authors:  Jerry J Fong; Brenda L Nguyen; Robert Bridger; Estela E Medrano; Lance Wells; Shujuan Pan; Richard N Sifers
Journal:  J Biol Chem       Date:  2012-02-27       Impact factor: 5.157

5.  Enzymatic addition of O-GlcNAc to nuclear and cytoplasmic proteins. Identification of a uridine diphospho-N-acetylglucosamine:peptide beta-N-acetylglucosaminyltransferase.

Authors:  R S Haltiwanger; G D Holt; G W Hart
Journal:  J Biol Chem       Date:  1990-02-15       Impact factor: 5.157

6.  A Polycomb group protein complex with sequence-specific DNA-binding and selective methyl-lysine-binding activities.

Authors:  Tetyana Klymenko; Bernadett Papp; Wolfgang Fischle; Thomas Köcher; Malgorzata Schelder; Cornelia Fritsch; Brigitte Wild; Matthias Wilm; Jürg Müller
Journal:  Genes Dev       Date:  2006-04-17       Impact factor: 11.361

7.  Purification and characterization of an O-GlcNAc selective N-acetyl-beta-D-glucosaminidase from rat spleen cytosol.

Authors:  D L Dong; G W Hart
Journal:  J Biol Chem       Date:  1994-07-29       Impact factor: 5.157

8.  Roles of the tetratricopeptide repeat domain in O-GlcNAc transferase targeting and protein substrate specificity.

Authors:  Sai Prasad N Iyer; Gerald W Hart
Journal:  J Biol Chem       Date:  2003-04-30       Impact factor: 5.157

9.  Ten-eleven translocation 1 (Tet1) is regulated by O-linked N-acetylglucosamine transferase (Ogt) for target gene repression in mouse embryonic stem cells.

Authors:  Feng-Tao Shi; Hyeung Kim; Weisi Lu; Quanyuan He; Dan Liu; Margaret A Goodell; Ma Wan; Zhou Songyang
Journal:  J Biol Chem       Date:  2013-05-31       Impact factor: 5.157

10.  Ras-induced changes in H3K27me3 occur after those in transcriptional activity.

Authors:  Masaki Hosogane; Ryo Funayama; Yuichiro Nishida; Takeshi Nagashima; Keiko Nakayama
Journal:  PLoS Genet       Date:  2013-08-29       Impact factor: 5.917

View more
  110 in total

1.  Epigenetic modification of histone 3 lysine 27: mediator subunit MED25 is required for the dissociation of polycomb repressive complex 2 from the promoter of cytochrome P450 2C9.

Authors:  Neal A Englert; George Luo; Joyce A Goldstein; Sailesh Surapureddi
Journal:  J Biol Chem       Date:  2014-11-12       Impact factor: 5.157

Review 2.  Nutrient regulation of signaling and transcription.

Authors:  Gerald W Hart
Journal:  J Biol Chem       Date:  2019-01-09       Impact factor: 5.157

Review 3.  Too sweet to resist: Control of immune cell function by O-GlcNAcylation.

Authors:  Tristan de Jesus; Sudhanshu Shukla; Parameswaran Ramakrishnan
Journal:  Cell Immunol       Date:  2018-06-02       Impact factor: 4.868

Review 4.  Regulation and role of post-translational modifications of enhancer of zeste homologue 2 in cancer development.

Authors:  Haiqi Lu; Guangliang Li; Chenyi Zhou; Wei Jin; Xiaoling Qian; Zhuo Wang; Hongming Pan; Hongchuan Jin; Xian Wang
Journal:  Am J Cancer Res       Date:  2016-12-01       Impact factor: 6.166

Review 5.  Diverse involvement of EZH2 in cancer epigenetics.

Authors:  Pamela Völkel; Barbara Dupret; Xuefen Le Bourhis; Pierre-Olivier Angrand
Journal:  Am J Transl Res       Date:  2015-02-15       Impact factor: 4.060

Review 6.  Protein O-GlcNAcylation and cardiovascular (patho)physiology.

Authors:  Susan A Marsh; Helen E Collins; John C Chatham
Journal:  J Biol Chem       Date:  2014-10-21       Impact factor: 5.157

Review 7.  Oligosaccharide Synthesis and Translational Innovation.

Authors:  Larissa Krasnova; Chi-Huey Wong
Journal:  J Am Chem Soc       Date:  2019-02-18       Impact factor: 15.419

8.  O-GlcNAcylation modulates Bmi-1 protein stability and potential oncogenic function in prostate cancer.

Authors:  Y Li; L Wang; J Liu; P Zhang; M An; C Han; Y Li; X Guan; K Zhang
Journal:  Oncogene       Date:  2017-07-17       Impact factor: 9.867

9.  O-GlcNAcylation Enhances Double-Strand Break Repair, Promotes Cancer Cell Proliferation, and Prevents Therapy-Induced Senescence in Irradiated Tumors.

Authors:  Elena V Efimova; Oliver K Appelbe; Natalia Ricco; Steve S-Y Lee; Yue Liu; Donald J Wolfgeher; Tamica N Collins; Amy C Flor; Aishwarya Ramamurthy; Sara Warrington; Vytautas P Bindokas; Stephen J Kron
Journal:  Mol Cancer Res       Date:  2019-03-18       Impact factor: 5.852

10.  Drosophila O-GlcNAcase Deletion Globally Perturbs Chromatin O-GlcNAcylation.

Authors:  Ilhan Akan; Dona C Love; Katryn R Harwood; Michelle R Bond; John A Hanover
Journal:  J Biol Chem       Date:  2016-03-08       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.